<DOC>
	<DOCNO>NCT00850746</DOCNO>
	<brief_summary>This study evaluate whether YM443 cause change electrocardiogram healthy adult .</brief_summary>
	<brief_title>A Study Evaluate Effect Repeat Oral Doses YM443 Cardiac Repolarization Healthy Adults</brief_title>
	<detailed_description>Each subject participate four treatment period separate washout period . In order maintain blind arm , subject receive number tablet per day period either active drug placebo .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<criteria>Healthy Male non pregnant , non lactate female Weighing least 45 kg Body Mass Index ( BMI ) 18 32 kg/m2 The subject evidence cardiac conduction abnormalities The subject previous history medical psychiatric condition would preclude participation study The subject participate another clinical trial last 30 day The subject anticipate inability abstain alcohol , caffeine use , grapefruit grapefruit juice 48 hour prior administration first dose YM443 Day 1 Period 1 throughout duration study The subject use tobaccocontaining product nicotine nicotinecontaining product within six month prior Screening The subject consume 5 unit alcoholic beverage ( one unit 12 ounce beer , 4 ounce wine 1 ounce spirit ) per week history substance abuse , drug addiction , alcoholism within 2 year prior Screening The subject donate whole blood cellular blood component undergone significant loss blood receive transfusion blood blood product within 56 day Day 1 Period 1 donate plasma within 7 day Day 1 Period 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>QT interval</keyword>
	<keyword>Cardiac Repolarization</keyword>
	<keyword>Cardiac Conduction</keyword>
	<keyword>Healthy Subjects</keyword>
	<keyword>YM443 ( Z-338 , acotiamide hydrochloride )</keyword>
	<keyword>Evaluation QT Interval</keyword>
</DOC>